This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

Sun Pharmaceuticals UK Ltd

4100 Park Approach, Thorpe Park, Leeds, LS15 8GB, UK
Telephone: +44 (0) 113 397 0870
Fax: +44 (0) 113 341 0388
Medical Information Direct Line: +44 (0) 7787 433889
Medical Information e-mail:
Medical Information Fax: +44 (0) 113 341 0388
Out of Hours contact:

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 04/04/2013
PIL Octreotide solution for Injection ( Sun Pharmaceuticals UK Ltd )

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/04/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - marketing authorisation holder
Updated on 19/03/2010 and displayed until 04/04/2013
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to MA holder contact details
Updated on 07/07/2008 and displayed until 19/03/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics